| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 25, 2024Virtual Press Office and PR Newswire: General Trade show news
Data from a wide range of the Sun Pharma dermatology portfolio, including data on alopecia areata, psoriasis, acne and actinic keratosis products, will be highlighted during the meeting. MUMBAI, India
-
Oct 25, 2024Virtual Press Office and PR Newswire: General Trade show news
In first dedicated study of a selective IL-13 inhibitor in patients previously treated with dupilumab, the majority of patients had a history of inadequate response to dupilumab EBGLYSS also...
-
Oct 25, 2024Virtual Press Office and PR Newswire: General Trade show news
~33% ORR by RECIST 1.1: 1 CR + 8 PRs out of 27 evaluable heavily pre-treated (median 2-3 prior lines, ranging from 1-7) MTAP-deletion UC and NSCLC patients 9 of 9 responses have confirmed by...
-
Oct 25, 2024Virtual Press Office and PR Newswire: General Trade show news
GTCHAIR rocked the stage at the 2024 ORGATEC furniture exhibition in Cologne, Germany. Their booth, located at Hall 8.1 A060, showcased a cool range of office chairs that make sitting comfy and...
-
Oct 25, 2024Virtual Press Office and PR Newswire: General Trade show news
On October 24, 2024, TASTE-2, a Chinese innovative stroke drug study led by Professor Wang Yongjun from Beijing Tiantan Hospital, was published in an oral report at the 16th World Stroke...
